Please login to the form below

Not currently logged in
Email:
Password:

fingolimod

This page shows the latest fingolimod news and features for those working in and with pharma, biotech and healthcare.

FDA turns down Celgene’s filing for multiple sclerosis drug

FDA turns down Celgene’s filing for multiple sclerosis drug

So far there is just one S1P modulator - Novartis’Gilenya (fingolimod) - on the market.

Latest news

More from news
Approximately 4 fully matching, plus 100 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Random42 Scientific Communication

    2011 – Silver. Communicator Awards - PolyXen. 2010 – Gold. Aurora Awards - Fingolimod in Multiple Sclerosis. ... Worldfest - Plant Sterol MOA. 2010 - Silver. Worldfest - Fingolimod in Multiple Sclerosis.

  • Random42 Scientific Communication

    2011 – Silver. Communicator Awards - PolyXen. 2010 – Gold. Aurora Awards - Fingolimod in Multiple Sclerosis. ... Worldfest - Plant Sterol MOA. 2010 - Silver. Worldfest - Fingolimod in Multiple Sclerosis.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics